Cargando…

COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group

Multisystemic inflammatory syndrome (MIS-C) diagnosis remains difficult because the clinical features overlap with Kawasaki disease (KD). The study aims to highlight the clinical and laboratory features and outcomes of patients with MISC whose clinical manifestations overlap with or without KD. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Yilmaz Ciftdogan, Dilek, Ekemen Keles, Yildiz, Cetin, Benhur Sirvan, Dalgic Karabulut, Nazan, Emiroglu, Melike, Bagci, Zafer, Buyukcam, Ayse, Erdeniz, Emine Hafize, Arga, Gul, Yesil, Edanur, Cakici, Ozlem, Karbuz, Adem, Sahbudak Bal, Zumrut, Kara, Soner Sertan, Ozer, Arife, Metin Akcan, Ozge, Elmas Bozdemir, Sefika, Anil, Ayse Berna, Uygun, Hatice, Kilic, Omer, Hancerli Torun, Selda, Umit, Zuhal, Sutcu, Murat, Ozgokce Ozmen, Berfin, Karaoglu Asrak, Hatice, Alkan, Gulsum, Kara Aksay, Ahu, Ugur, Cuneyt, Birbilen, Ahmet Ziya, Bursal Duramaz, Burcu, Akyuz Ozkan, Esra, Burakay, Ozgur, Yildirim Arslan, Sema, Karadag Oncel, Eda, Celik, Serkan Fazli, Kilic, Ahmet Osman, Ozen, Seval, Sarikaya, Remzi, Demirkol, Demet, Arslan, Gazi, Turel, Ozden, Sert, Ahmet, Sari, Ergul, Orbak, Zerrin, Sahin, Irfan Oguz, Varan, Celal, Akturk, Hacer, Tuter Oz, Sadiye Kubra, Durak, Fatih, Oflaz, Mehmet Burhan, Kara, Manolya, Karpuz, Derya, Talip Petmezci, Mey, Hatipoglu, Nevin, Oncel, Selim, Turgut, Mehmet, Elmali, Ferhan, Somer, Ayper, Kuyucu, Necdet, Dinleyici, Ener Cagri, Kurugöl, Zafer, Ciftci, Ergin, Kara, Ates
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819197/
https://www.ncbi.nlm.nih.gov/pubmed/35129668
http://dx.doi.org/10.1007/s00431-022-04390-2
_version_ 1784646005112700928
author Yilmaz Ciftdogan, Dilek
Ekemen Keles, Yildiz
Cetin, Benhur Sirvan
Dalgic Karabulut, Nazan
Emiroglu, Melike
Bagci, Zafer
Buyukcam, Ayse
Erdeniz, Emine Hafize
Arga, Gul
Yesil, Edanur
Cakici, Ozlem
Karbuz, Adem
Sahbudak Bal, Zumrut
Kara, Soner Sertan
Ozer, Arife
Metin Akcan, Ozge
Elmas Bozdemir, Sefika
Anil, Ayse Berna
Uygun, Hatice
Kilic, Omer
Hancerli Torun, Selda
Umit, Zuhal
Sutcu, Murat
Ozgokce Ozmen, Berfin
Karaoglu Asrak, Hatice
Alkan, Gulsum
Kara Aksay, Ahu
Ugur, Cuneyt
Birbilen, Ahmet Ziya
Bursal Duramaz, Burcu
Akyuz Ozkan, Esra
Burakay, Ozgur
Yildirim Arslan, Sema
Karadag Oncel, Eda
Celik, Serkan Fazli
Kilic, Ahmet Osman
Ozen, Seval
Sarikaya, Remzi
Demirkol, Demet
Arslan, Gazi
Turel, Ozden
Sert, Ahmet
Sari, Ergul
Orbak, Zerrin
Sahin, Irfan Oguz
Varan, Celal
Akturk, Hacer
Tuter Oz, Sadiye Kubra
Durak, Fatih
Oflaz, Mehmet Burhan
Kara, Manolya
Karpuz, Derya
Talip Petmezci, Mey
Hatipoglu, Nevin
Oncel, Selim
Turgut, Mehmet
Elmali, Ferhan
Somer, Ayper
Kuyucu, Necdet
Dinleyici, Ener Cagri
Kurugöl, Zafer
Ciftci, Ergin
Kara, Ates
author_facet Yilmaz Ciftdogan, Dilek
Ekemen Keles, Yildiz
Cetin, Benhur Sirvan
Dalgic Karabulut, Nazan
Emiroglu, Melike
Bagci, Zafer
Buyukcam, Ayse
Erdeniz, Emine Hafize
Arga, Gul
Yesil, Edanur
Cakici, Ozlem
Karbuz, Adem
Sahbudak Bal, Zumrut
Kara, Soner Sertan
Ozer, Arife
Metin Akcan, Ozge
Elmas Bozdemir, Sefika
Anil, Ayse Berna
Uygun, Hatice
Kilic, Omer
Hancerli Torun, Selda
Umit, Zuhal
Sutcu, Murat
Ozgokce Ozmen, Berfin
Karaoglu Asrak, Hatice
Alkan, Gulsum
Kara Aksay, Ahu
Ugur, Cuneyt
Birbilen, Ahmet Ziya
Bursal Duramaz, Burcu
Akyuz Ozkan, Esra
Burakay, Ozgur
Yildirim Arslan, Sema
Karadag Oncel, Eda
Celik, Serkan Fazli
Kilic, Ahmet Osman
Ozen, Seval
Sarikaya, Remzi
Demirkol, Demet
Arslan, Gazi
Turel, Ozden
Sert, Ahmet
Sari, Ergul
Orbak, Zerrin
Sahin, Irfan Oguz
Varan, Celal
Akturk, Hacer
Tuter Oz, Sadiye Kubra
Durak, Fatih
Oflaz, Mehmet Burhan
Kara, Manolya
Karpuz, Derya
Talip Petmezci, Mey
Hatipoglu, Nevin
Oncel, Selim
Turgut, Mehmet
Elmali, Ferhan
Somer, Ayper
Kuyucu, Necdet
Dinleyici, Ener Cagri
Kurugöl, Zafer
Ciftci, Ergin
Kara, Ates
author_sort Yilmaz Ciftdogan, Dilek
collection PubMed
description Multisystemic inflammatory syndrome (MIS-C) diagnosis remains difficult because the clinical features overlap with Kawasaki disease (KD). The study aims to highlight the clinical and laboratory features and outcomes of patients with MISC whose clinical manifestations overlap with or without KD. This study is a retrospective analysis of a case series designed for patients aged 1 month to 18 years in 28 hospitals between November 1, 2020, and June 9, 2021. Patient demographics, complaints, laboratory results, echocardiographic results, system involvement, and outcomes were recorded. A total of 614 patients were enrolled; the median age was 7.4 years (interquartile range (IQR) 3.9–12 years). A total of 277 (45.1%) patients with MIS-C had manifestations that overlapped with KD, including 92 (33.3%) patients with complete KD and 185 (66.7%) with incomplete KD. Lymphocyte and platelet counts were significantly lower in patients with MISC, overlapped with KD (lymphocyte count 1080 vs. 1280 cells × μL, p = 0.028; platelet count 166 vs. 216 cells × 10(3)/μL, p < 0.001). The median serum procalcitonin levels were statistically higher in patients overlapped with KD (3.18 vs. 1.68 µg/L, p = 0.001). Coronary artery dilatation was statistically significant in patients with overlap with KD (13.4% vs. 6.8%, p = 0.007), while myocarditis was significantly more common in patients without overlap with KD features (2.6% vs 7.4%, p = 0.009). The association between clinical and laboratory findings and overlap with KD was investigated. Age > 12 years reduced the risk of overlap with KD by 66% (p < 0.001, 95% CI 0.217–0.550), lethargy increased the risk of overlap with KD by 2.6-fold (p = 0.011, 95% CI 1.244–5.439), and each unit more albumin (g/dl) reduced the risk of overlap with KD by 60% (p < 0.001, 95% CI 0.298–0.559). Conclusion: Almost half of the patients with MISC had clinical features that overlapped with KD; in particular, incomplete KD was present. The median age was lower in patients with KD-like features. Lymphocyte and platelet counts were lower, and ferritin and procalcitonin levels were significantly higher in patients with overlap with KD.
format Online
Article
Text
id pubmed-8819197
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-88191972022-02-07 COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group Yilmaz Ciftdogan, Dilek Ekemen Keles, Yildiz Cetin, Benhur Sirvan Dalgic Karabulut, Nazan Emiroglu, Melike Bagci, Zafer Buyukcam, Ayse Erdeniz, Emine Hafize Arga, Gul Yesil, Edanur Cakici, Ozlem Karbuz, Adem Sahbudak Bal, Zumrut Kara, Soner Sertan Ozer, Arife Metin Akcan, Ozge Elmas Bozdemir, Sefika Anil, Ayse Berna Uygun, Hatice Kilic, Omer Hancerli Torun, Selda Umit, Zuhal Sutcu, Murat Ozgokce Ozmen, Berfin Karaoglu Asrak, Hatice Alkan, Gulsum Kara Aksay, Ahu Ugur, Cuneyt Birbilen, Ahmet Ziya Bursal Duramaz, Burcu Akyuz Ozkan, Esra Burakay, Ozgur Yildirim Arslan, Sema Karadag Oncel, Eda Celik, Serkan Fazli Kilic, Ahmet Osman Ozen, Seval Sarikaya, Remzi Demirkol, Demet Arslan, Gazi Turel, Ozden Sert, Ahmet Sari, Ergul Orbak, Zerrin Sahin, Irfan Oguz Varan, Celal Akturk, Hacer Tuter Oz, Sadiye Kubra Durak, Fatih Oflaz, Mehmet Burhan Kara, Manolya Karpuz, Derya Talip Petmezci, Mey Hatipoglu, Nevin Oncel, Selim Turgut, Mehmet Elmali, Ferhan Somer, Ayper Kuyucu, Necdet Dinleyici, Ener Cagri Kurugöl, Zafer Ciftci, Ergin Kara, Ates Eur J Pediatr Original Article Multisystemic inflammatory syndrome (MIS-C) diagnosis remains difficult because the clinical features overlap with Kawasaki disease (KD). The study aims to highlight the clinical and laboratory features and outcomes of patients with MISC whose clinical manifestations overlap with or without KD. This study is a retrospective analysis of a case series designed for patients aged 1 month to 18 years in 28 hospitals between November 1, 2020, and June 9, 2021. Patient demographics, complaints, laboratory results, echocardiographic results, system involvement, and outcomes were recorded. A total of 614 patients were enrolled; the median age was 7.4 years (interquartile range (IQR) 3.9–12 years). A total of 277 (45.1%) patients with MIS-C had manifestations that overlapped with KD, including 92 (33.3%) patients with complete KD and 185 (66.7%) with incomplete KD. Lymphocyte and platelet counts were significantly lower in patients with MISC, overlapped with KD (lymphocyte count 1080 vs. 1280 cells × μL, p = 0.028; platelet count 166 vs. 216 cells × 10(3)/μL, p < 0.001). The median serum procalcitonin levels were statistically higher in patients overlapped with KD (3.18 vs. 1.68 µg/L, p = 0.001). Coronary artery dilatation was statistically significant in patients with overlap with KD (13.4% vs. 6.8%, p = 0.007), while myocarditis was significantly more common in patients without overlap with KD features (2.6% vs 7.4%, p = 0.009). The association between clinical and laboratory findings and overlap with KD was investigated. Age > 12 years reduced the risk of overlap with KD by 66% (p < 0.001, 95% CI 0.217–0.550), lethargy increased the risk of overlap with KD by 2.6-fold (p = 0.011, 95% CI 1.244–5.439), and each unit more albumin (g/dl) reduced the risk of overlap with KD by 60% (p < 0.001, 95% CI 0.298–0.559). Conclusion: Almost half of the patients with MISC had clinical features that overlapped with KD; in particular, incomplete KD was present. The median age was lower in patients with KD-like features. Lymphocyte and platelet counts were lower, and ferritin and procalcitonin levels were significantly higher in patients with overlap with KD. Springer Berlin Heidelberg 2022-02-07 2022 /pmc/articles/PMC8819197/ /pubmed/35129668 http://dx.doi.org/10.1007/s00431-022-04390-2 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Yilmaz Ciftdogan, Dilek
Ekemen Keles, Yildiz
Cetin, Benhur Sirvan
Dalgic Karabulut, Nazan
Emiroglu, Melike
Bagci, Zafer
Buyukcam, Ayse
Erdeniz, Emine Hafize
Arga, Gul
Yesil, Edanur
Cakici, Ozlem
Karbuz, Adem
Sahbudak Bal, Zumrut
Kara, Soner Sertan
Ozer, Arife
Metin Akcan, Ozge
Elmas Bozdemir, Sefika
Anil, Ayse Berna
Uygun, Hatice
Kilic, Omer
Hancerli Torun, Selda
Umit, Zuhal
Sutcu, Murat
Ozgokce Ozmen, Berfin
Karaoglu Asrak, Hatice
Alkan, Gulsum
Kara Aksay, Ahu
Ugur, Cuneyt
Birbilen, Ahmet Ziya
Bursal Duramaz, Burcu
Akyuz Ozkan, Esra
Burakay, Ozgur
Yildirim Arslan, Sema
Karadag Oncel, Eda
Celik, Serkan Fazli
Kilic, Ahmet Osman
Ozen, Seval
Sarikaya, Remzi
Demirkol, Demet
Arslan, Gazi
Turel, Ozden
Sert, Ahmet
Sari, Ergul
Orbak, Zerrin
Sahin, Irfan Oguz
Varan, Celal
Akturk, Hacer
Tuter Oz, Sadiye Kubra
Durak, Fatih
Oflaz, Mehmet Burhan
Kara, Manolya
Karpuz, Derya
Talip Petmezci, Mey
Hatipoglu, Nevin
Oncel, Selim
Turgut, Mehmet
Elmali, Ferhan
Somer, Ayper
Kuyucu, Necdet
Dinleyici, Ener Cagri
Kurugöl, Zafer
Ciftci, Ergin
Kara, Ates
COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group
title COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group
title_full COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group
title_fullStr COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group
title_full_unstemmed COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group
title_short COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group
title_sort covid-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with kawasaki disease-turk mis-c study group
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819197/
https://www.ncbi.nlm.nih.gov/pubmed/35129668
http://dx.doi.org/10.1007/s00431-022-04390-2
work_keys_str_mv AT yilmazciftdogandilek covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT ekemenkelesyildiz covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT cetinbenhursirvan covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT dalgickarabulutnazan covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT emiroglumelike covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT bagcizafer covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT buyukcamayse covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT erdenizeminehafize covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT argagul covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT yesiledanur covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT cakiciozlem covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT karbuzadem covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT sahbudakbalzumrut covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT karasonersertan covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT ozerarife covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT metinakcanozge covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT elmasbozdemirsefika covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT anilayseberna covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT uygunhatice covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT kilicomer covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT hancerlitorunselda covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT umitzuhal covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT sutcumurat covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT ozgokceozmenberfin covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT karaogluasrakhatice covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT alkangulsum covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT karaaksayahu covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT ugurcuneyt covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT birbilenahmetziya covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT bursalduramazburcu covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT akyuzozkanesra covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT burakayozgur covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT yildirimarslansema covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT karadagonceleda covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT celikserkanfazli covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT kilicahmetosman covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT ozenseval covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT sarikayaremzi covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT demirkoldemet covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT arslangazi covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT turelozden covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT sertahmet covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT sariergul covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT orbakzerrin covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT sahinirfanoguz covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT varancelal covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT akturkhacer covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT tuterozsadiyekubra covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT durakfatih covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT oflazmehmetburhan covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT karamanolya covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT karpuzderya covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT talippetmezcimey covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT hatipoglunevin covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT oncelselim covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT turgutmehmet covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT elmaliferhan covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT somerayper covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT kuyucunecdet covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT dinleyicienercagri covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT kurugolzafer covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT ciftciergin covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup
AT karaates covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup